Multidisciplinary quality program shown to cut side effects of androgen deprivation therapy in prostate cancer
Dr Hafron discussed a recent study that evaluated a multidisciplinary quality initiative aimed at reducing adverse events linked to androgen deprivation therapy for prostate cancer.
The program coordinated urologists, oncologists, nurses and pharmacists to standardize monitoring, adjust dosing and provide supportive care, according to the study findings.
Early results indicated fewer treatment-related side effects and improved patient management, suggesting that coordinated care models can enhance outcomes for men receiving ADT.
This writeup was produced by pharmadog from original reporting by onclive. The original article may no longer be reachable at its published URL.
Original headline: “Dr Hafron on a Multidisciplinary Quality Initiative Designed to Mitigate the AEs of ADT in Prostate Cancer”
read at onclive ↗
comments(0)
5-min edit window · permanent after that